WHO ICTRP trial
Vascular function and Antiplatelet effects on switching from Clopidgrel to…
JPRN-UMIN000023756 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-UMIN000023756 |
|---|---|
| Public title | Vascular function and Antiplatelet effects on switching from Clopidgrel to Prasugrel in chronic phase after percutaneous coronary intervention |
| Scientific title | Vascular function and Antiplatelet effects on switching from Clopidgrel to Prasugrel in chronic phase after percutaneous coronary intervention - Switch-Pras study |
| Primary sponsor | Department of Cardiovascular Medicine,Dokkyo Medical University |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | The patients on DAPT after PCI who underwent follow-up coronary angiography |
| Interventions | Clopidgrel with Aspirin group Aspirin is 81mg X1 Clopidgrel is 75mg X1 Prasugrel with Aspirin group Aspirin is 81mg X1 Prasugrel is 3.75mg X1 |
| Registration date | Jan 9, 2016 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: